Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-26-049429
Filing Date
2026-04-29
Accepted
2026-04-29 17:29:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0288318-424b3_cadrenal.htm 424B3 196520
2 GRAPHIC ea028831801_img1.jpg GRAPHIC 4883
  Complete submission text file 0001213900-26-049429.txt   204423
Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-295200 | Film No.: 26918246
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)